Article Details

Monoclonal Antibody Oncology Biosimilars Market to Expand 4.0x by 2025

Retrieved on: 2021-04-05 06:33:45

Tags for this article:

Click the tags to see associated articles and topics

Monoclonal Antibody Oncology Biosimilars Market to Expand 4.0x by 2025. View article details on hiswai:

Excerpt

Rising adoption of chemotherapy is the key growth driver of the segment. However, monoclonal antibodies are set to grow the fastest, expanding 4.0x, ...

Article found on: www.flanewsonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up